Media coverage
1
Media coverage
Title Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma; Daniel V. T. Catenacci, MD, and colleagues present findings from a study of cir Media name/outlet CancerNetwork Country/Territory United States Date 27/04/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=683Y-79Y1-JCXN-V01M-00000-00 Persons Ki Ho Park, Hong Jun Kim, Kyung Sun Park, Sunghun Jin